Lanzamiento Enero 2027

Reporte de caso2020Acceso abierto

Sudden Caffeine Withdrawal Triggers Migraine-A Randomized Controlled Trial

Alstadhaug KB, Ofte HK, Müller KI, Andreou AP

Frontiers in neurology · 18 citas

Cómo se estudió

Diseño
Reporte de caso (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente

Según la declaración de financiación del texto completo.

Publicación

Publicado
2020-09-10 · Front Neurol · vol. 11 · pág. 1002
Editorial
Frontiers Media
Citado
36 citas · más que el 86% de estudios similares · 1.9× el promedio de su campo
Referencias
41 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Migraine and Headache Studies · Neuroscience of respiration and sleep · Medicinal Plant Extracts Effects
Palabras clave
Caffeine, Migraine, Placebo, Medicine, Crossover study, Pittsburgh Sleep Quality Index, Anesthesia, Randomized controlled trial, Internal medicine, Sleep quality, Pharmacology, Insomnia

4 autores

  • Karl Bjørnar Alstadhaug🇳🇴 · autor de correspondenciaNordland Hospital Trust; UiT The Arctic University of Norway
  • Hilde Karen Ofte🇳🇴Nordland Hospital Trust
  • Kai Ivar Müller🇳🇴University Hospital of North Norway; UiT The Arctic University of Norway
  • Anna P. Andreou🇬🇧King's College London; Guy's and St Thomas' NHS Foundation Trust

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective: Assessing the effects of caffeine withdrawal on migraine. Background: The effects of caffeine withdrawal on migraineurs are at large unknown. Methods: This was a randomized, double-blind, crossover study (NCT03022838), designed to enroll 80 adults with episodic migraine and a daily consumption of 300-800 mg caffeine. Participants substituted their estimated dietary caffeine with either placebo capsules or capsulated caffeine tablets for 5 weeks before switching the comparators for 5 more weeks. Results: The study was terminated due to low recruitment. Ten subjects with a mean age of 46.3 ± 9.9 years, BMI of 24.9 ± 3.7, and a mean blood pressure of 134/83 ± 17/12 mmHg were enrolled. The average consumption of caffeine per day was 539 ± 196.3 mg. The average monthly headache days and migraine attack frequency at baseline was 11.5 ± 4.9 and 5.2 ± 1.2, respectively. At baseline Pittsburgh Sleep Quality Index was 5.8 ± 2.5 and HIT-6 was 62.8 ± 3.9. There were no differences in these or in parameters from actigraphy during the caffeine period compared with the placebo period. One subject withdrew just after entering the study. In the remaining nine, withdrawal triggered severe migraine attacks in seven, causing one more drop-out, and a typical caffeine withdrawal syndrome in two. Caffeine continuation did not trigger migraines, but one attack occurred in the wake of caffeine reintroduction. Conclusions: The study failed to answer how caffeine withdrawal affects migraineurs over time, but showed that abrupt withdrawal of caffeine is a potent trigger for migraine attacks.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.